Sign in to continue:

Tuesday, February 24th, 2026

Tian Tu Capital Completes Major Transaction: Disposal of 86.96% Minority Interest in Yoplait China for RMB 1.57 Billion





Tian Tu Capital Completes Major Disposal of Yoplait China Stake

Tian Tu Capital Completes Major Disposal of Yoplait China Stake

Key Highlights for Investors

  • Completion of Major Transaction: Tian Tu Capital Co., Ltd. (“the Company”) has completed the disposal of its minority equity interest in Yoplait China, a significant transaction for the Company and its shareholders.
  • Transaction Size and Details: The Company, together with its associates (measured using the equity method), has agreed to sell approximately 86.96% of the equity interest in Yoplait China to an independent purchaser. The aggregate consideration for this disposal amounts to a substantial RMB 1,565,217,391.
  • Completion Date: The transaction has now been completed in accordance with the terms and conditions set out in the Share Purchase Agreement.
  • Change in Financial Reporting: Following this transaction, the Company no longer holds any equity interest in Yoplait China. As a result, Yoplait China will no longer be classified as an associate measured at fair value in the Company’s consolidated financial statements.

Details and Analysis

Tian Tu Capital Co., Ltd., a joint stock company incorporated in the People’s Republic of China and listed on the Hong Kong Stock Exchange (Stock Code: 1973), has disclosed the completion of a major transaction involving the disposal of its minority stake in Yoplait China. This transaction was first announced on December 1, 2025 and was subsequently approved by shareholders at an Extraordinary General Meeting, as per the circular issued on January 14, 2026.

The disposal involves the sale of approximately 86.96% of Yoplait China’s equity to a third-party purchaser, for an aggregate consideration of RMB 1.565 billion. This is a significant sum and represents a major divestment of the Company’s interests in the Chinese dairy and yogurt sector. The completion of the transaction marks the Company’s full exit from any equity ownership in Yoplait China.

The proceeds from this sale are likely to have a material impact on the Company’s financial position, potentially strengthening its cash reserves and allowing for redeployment of capital into other strategic investments. Shareholders should note that with Yoplait China no longer being classified as an associate, this may have accounting and valuation implications for Tian Tu Capital’s future financial statements.

The transaction may be price-sensitive, as it represents both the realization of a substantial investment and a notable change in the Company’s investment portfolio. Investors should monitor further disclosures regarding the intended use of proceeds and any strategic shifts in the Company’s investment strategy.

Board Composition

As of the date of the announcement, the Board is comprised of three executive directors (Mr. Wang Yonghua, Mr. Feng Weidong, and Ms. Zou Yunli), three non-executive directors (Mr. Wang Shisheng, Mr. Li Lan, and Ms. Yao Jiawen), and three independent non-executive directors (Mr. Wang Shilin, Mr. Diao Yang, and Mr. Tsai Lieh, alias Tsai Leo).

What Shareholders Need to Know

  • This transaction marks a significant change in the Company’s asset base and investment profile.
  • The cash consideration received could be deployed towards new investments, repaying debt, or other corporate purposes, potentially impacting future earnings and share value.
  • The removal of Yoplait China from the Company’s associate holdings will affect how the Company’s financial results are consolidated and reported.

Potential Share Price Impact

Given the size of the transaction and the change in asset composition, this news could be market-moving. Shareholders and potential investors should stay alert for further announcements regarding the strategic redeployment of proceeds or any special distributions that may arise as a result of this sale.


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should review official disclosures and consult with their financial advisors before making any investment decisions. The information herein is based on the Company’s public announcement and may be subject to further updates or clarifications.




View TIAN TU CAPITAL Historical chart here



Clifford Modern Living Announces Major Precious Metals Investments Including Allocated Gold, Silver, and Unallocated Gold under HKEX Listing Rules 1

Clifford Modern Living Holdings Major Transaction: Precious Metals Investment Clifford Modern Living Holdings Announces Major Investment in Precious Metals Key Highlights Major Transaction: Clifford Modern Living Holdings Limited (“the Company”) has announced a major...

Kingboard Holdings Announces Over 165% Surge in Net Profit for 2025 Driven by Robust Laminates and Investment Business Demand

Kingboard Holdings Limited Issues Positive Profit Alert for FY2025 Kingboard Holdings Limited Announces Significant Profit Surge for 2025 Key Highlights Substantial Increase in Net Profit: Kingboard Holdings Limited (“KBH”) expects to record a net...

Sunshine Lake Pharma’s HEC-648 Monoclonal Antibody for Nipah Virus Accepted by China National Medical Products Administration for Clinical Trials

Sunshine Lake Pharma Co., Ltd. Announces Acceptance of IND Application for Groundbreaking Nipah Virus Monoclonal Antibody Sunshine Lake Pharma Co., Ltd. Announces Acceptance of IND Application for Groundbreaking Nipah Virus Monoclonal Antibody Key Highlights...

   Ad